Agios Pharmaceuticals, Inc. (AGIO)
28.14
-0.65
(-2.26%)
USD |
NASDAQ |
May 22, 16:00
28.13
-0.01
(-0.04%)
After-Hours: 20:00
Agios Pharmaceuticals EPS Diluted (Quarterly) : -1.686 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Apellis Pharmaceuticals, Inc. | 0.142 |
| Amgen, Inc. | 3.344 |
| MannKind Corp. | -0.0539 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -99.11M |
| Revenue (Quarterly) | 20.75M |
| Total Expenses (Quarterly) | 119.86M |
| Enterprise Value | 972.24M |
| Gross Profit Margin (Quarterly) | 87.07% |
| Profit Margin (Quarterly) | -477.7% |
| Earnings Yield | -25.77% |
| Normalized Earnings Yield | -25.77 |